SS
NURO

Steve Schonfeld’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Steve Schonfeld’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,813
Closed -$309K – 2636
2021
Q3 		$309K Buy
+3,813
New +$341K ﹤0.01% 1512

Other funds holding NURO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
SC
Stephens Consulting Flint, Michigan $309M AUM 14.46% 1-Year Est. Return

Steve Schonfeld's NURO Position: Q4 2021 in Review

Steve Schonfeld sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2021, closing a stake of 3,813 shares — an estimated $309K sold.

Steve Schonfeld first reported a position in NURO in Q3 2021 and held it in 1 quarter. The position peaked at $309K in Q3 2021. 17 funds tracked by Wall St. Rank hold NURO as of Q4 2021.

  • Steve Schonfeld reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Steve Schonfeld sold 3,813 NeuroMetrix, Inc. Common Stock shares in Q4 2021, an estimated $309K.
  • Steve Schonfeld first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Steve Schonfeld's NeuroMetrix, Inc. Common Stock position peaked at $309K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.